Abstract
Hypereosinophilia is usually defined as a blood eosinophil count >1500/μL. A broad variety of conditions are associated with hypereosinophilia. The present report describes three cases of hypereosinophilia, in which a thorough history, physical examination, laboratory and imaging investigations were unable to detect any abnormalities. Albendazole was empirically administered in all three cases, with complete normalization of eosinophil counts thereafter. Empirical treatment with albendazole for patients presenting with hypereosinophilia should be strongly considered.
| Original language | English |
|---|---|
| Pages (from-to) | 323-324 |
| Number of pages | 2 |
| Journal | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Volume | 26 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1 Nov 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Albendazole
- Hypereosinophilia
- Hypereosinophilic syndrome
Fingerprint
Dive into the research topics of 'The role of empirical albendazole treatment in idiopathic hypereosinophilia - A case series'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver